NYSE ARCA | ETF
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index.
The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies" products and services.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| STAA | STAAR Surgical Company | Healthcare | Medical Instruments & Supplies | 2.48% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.22% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.18% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.17% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 2.12% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.08% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.06% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 2.06% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.05% |
| ERF | Eurofins Scientific SE | Healthcare | Diagnostics & Research | 1.99% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 1.99% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.97% |
| AXGN | Axogen Inc | Healthcare | Medical Devices | 1.96% |
| SHL | Siemens Healthineers AG | Healthcare | Medical Devices | 1.89% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.86% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.86% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 1.85% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 1.84% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.84% |
| PHIA | Koninklijke Philips NV | Healthcare | Medical Devices | 1.84% |